Literature DB >> 21219679

Measurement of exhaled nitric oxide as a potential screening tool for pulmonary tuberculosis.

S C Van Beek1, N V Nhung, D N Sy, P J Sterk, E W Tiemersma, F G J Cobelens.   

Abstract

BACKGROUND: There is a need for low-technology, inexpensive screening tools for active tuberculosis (TB) case finding.
OBJECTIVE: to assess the potential usefulness of measuring exhaled nitric oxide (eNO).
DESIGN: Cross-sectional comparison in Hanoi, Viet Nam, comparing 90 consecutive smear-positive, culture-confirmed TB patients presenting at a referral hospital with office workers (no X-ray confirming TB) at this hospital (n = 52) and at a construction firm (n = 84). eNO levels were analysed using a validated handheld analyser.
RESULTS: eNO levels among TB patients (median 15 parts per billion [ppb], interquartile range [IQR] 10-20) were equal to those among construction firm workers (15 ppb, IQR 12-19, P = 0.517) but higher than those among hospital workers (8.5 ppb, IQR 5-12.5, P < 0.001). Taking the hospital workers as the comparison group, best performance as a diagnostic tool was at a cut-off of 10 ppb, with sensitivity 78% (95%CI 68-86) and specificity 62% (95%CI 47-75). Test characteristics could be optimised to 84% vs. 67% by excluding individuals who had recently smoked or consumed alcohol.
CONCLUSION: While eNO measurement has limited value in the direct diagnosis of pulmonary TB, it may be worth developing and evaluating as a cost-effective replacement of chest X-ray in screening algorithms of pulmonary TB where X-ray is not available.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219679

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

Review 1.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

Review 2.  Breath tests in respiratory and critical care medicine: from research to practice in current perspectives.

Authors:  Attapon Cheepsattayakorn; Ruangrong Cheepsattayakorn
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

Review 3.  A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas.

Authors:  Lyda Osorio; Jonny Alejandro Garcia; Luis Gabriel Parra; Victor Garcia; Laura Torres; Stéphanie Degroote; Valéry Ridde
Journal:  Infect Dis Poverty       Date:  2018-09-03       Impact factor: 4.520

4.  Diagnosis of tuberculosis through breath test: A systematic review.

Authors:  Antonia M I Saktiawati; David Dwi Putera; Althaf Setyawan; Yodi Mahendradhata; Tjip S van der Werf
Journal:  EBioMedicine       Date:  2019-08-08       Impact factor: 8.143

5.  Breath can discriminate tuberculosis from other lower respiratory illness in children.

Authors:  Lili Kang; Lesley Workman; Heather J Zar; Jane E Hill; Carly A Bobak; Lindy Bateman; Mohammad S Khan; Margaretha Prins; Lloyd May; Flavio A Franchina; Cynthia Baard; Mark P Nicol
Journal:  Sci Rep       Date:  2021-02-01       Impact factor: 4.379

Review 6.  A systematic review of potential screening biomarkers for active TB disease.

Authors:  James H Wykowski; Chris Phillips; Thao Ngo; Paul K Drain
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-11-05

Review 7.  Human Pulmonary Tuberculosis: Understanding the Immune Response in the Bronchoalveolar System.

Authors:  María Teresa Herrera; Silvia Guzmán-Beltrán; Karen Bobadilla; Teresa Santos-Mendoza; Mario Alberto Flores-Valdez; Luis Horacio Gutiérrez-González; Yolanda González
Journal:  Biomolecules       Date:  2022-08-20

8.  Measurement of fractional exhaled nitric oxide in stable bronchiectasis.

Authors:  Young-Jae Cho; Hyo-Jeong Lim; Jong Sun Park; Jae Ho Lee; Choon-Taek Lee; Ho Il Yoon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-01-31

9.  Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis.

Authors:  José W López; Maria-Cristina I Loader; Daniel Smith; Daniel Pastorius; Marjory Bravard; Luz Caviedes; Karina M Romero; Taryn Clark; William Checkley; Eduardo Ticona; Jon S Friedland; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2018-04-26       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.